Co-Authors
This is a "connection" page, showing publications co-authored by FRANCO DEMONTE and DIANA BELL.
Connection Strength
2.231
-
Whole-transcriptome analysis of chordoma of the skull base. Virchows Arch. 2016 Oct; 469(4):439-49.
Score: 0.557
-
Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology. J Exp Clin Cancer Res. 2022 Oct 04; 41(1):292.
Score: 0.214
-
High-grade transformation of low-grade biphenotypic sinonasal sarcoma: Radiological, morphophenotypic variation and confirmatory molecular analysis. Ann Diagn Pathol. 2022 Apr; 57:151889.
Score: 0.204
-
Multimodality Management of Recurrent Skull Base Chordomas: Factors Impacting Tumor Control and Disease-Specific Survival. Oper Neurosurg (Hagerstown). 2018 08 01; 15(2):131-143.
Score: 0.160
-
The First Reported Case of Primary Intestinal-type Adenocarcinoma of the Middle Ear and Review of the Literature. Otol Neurotol. 2017 10; 38(9):e364-e368.
Score: 0.151
-
Multimodality Treatment of Skull Base Chondrosarcomas: The Role of Histology Specific Treatment Protocols. Neurosurgery. 2017 Sep 01; 81(3):520-530.
Score: 0.151
-
Transcriptome comparison identifies potential biomarkers of spine and skull base chordomas. Virchows Arch. 2018 Mar; 472(3):489-497.
Score: 0.150
-
Neuroendocrine neoplasms of the sinonasal region. Head Neck. 2016 04; 38 Suppl 1:E2259-66.
Score: 0.130
-
Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol. 2015 Mar; 9(1):51-9.
Score: 0.120
-
Soft Tissue Sarcomas of the Head and Neck Region with Skull Base/Intracranial Invasion: Review of Surgical Outcomes and Multimodal Treatment Strategies: A Retrospective Case Series. Curr Oncol. 2022 09 14; 29(9):6540-6550.
Score: 0.053
-
Osteoblastoma of the Temporal Bone in a Child. Otol Neurotol. 2022 02 01; 43(2):e276-e278.
Score: 0.051
-
Long-Term Outcomes of Olfactory Neuroblastoma: MD Anderson Cancer Center Experience and Review of the Literature. Laryngoscope. 2022 02; 132(2):290-297.
Score: 0.049
-
Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies. Laryngoscope. 2021 05; 131(5):E1468-E1475.
Score: 0.047
-
Surgical management of carcinomas of the infratemporal fossa and skull base: patterns of failure and predictors of long-term outcomes. J Neurosurg. 2021 05 01; 134(5):1392-1398.
Score: 0.046
-
Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma. J Clin Oncol. 2019 02 20; 37(6):504-512.
Score: 0.041
-
Prognostic factors and survival in adenoid cystic carcinoma of the sinonasal cavity. Head Neck. 2018 12; 40(12):2596-2605.
Score: 0.041
-
Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb. Laryngoscope. 2018 06; 128(6):1274-1280.
Score: 0.038
-
Esthesioneuroblastoma. Neurosurg Clin N Am. 2013 Jan; 24(1):51-65.
Score: 0.027